================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
SCHEDULE l3D/A
Under
THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 2)
IVAX CORPORATION
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, Par Value $.10 per Share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
46582310
- --------------------------------------------------------------------------------
(CUSIP Number)
with a copy to:
Milan A. Sawdei, Esq. Peter H. Ehrenberg, Esq.
Bergen Brunswig Corporation LOWENSTEIN SANDLER PC
4000 Metropolitan Drive 65 Livingston Avenue
Orange, California 92868-3510 Roseland, New Jersey 07068
(714) 385-4000 (973) 597-2500
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Persons
Authorized to Receive Notices and Communications)
August 15, 1997
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule l3G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box. [ ]
Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule l3d-1(a) for other parties to whom copies are to be
sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
================================================================================
B2547/110
11/04/98SCH13D98.DOC
<PAGE>
CUSIP NO. 46582310
- --------------------------------------------------------------------------------
1) Names of Reporting Persons (I.R.S. Identification No. of Above
Person):
Bergen Brunswig Corporation
I.R.S. Identification No. 22-1444512
- --------------------------------------------------------------------------------
2) Check the Appropriate Box if a Member of a Group (See Instructions):
(a)
(b)
- --------------------------------------------------------------------------------
3) SEC Use Only
- --------------------------------------------------------------------------------
4) Source of Funds (See Instructions): Not Applicable
- --------------------------------------------------------------------------------
5) Check if Disclosure of Legal Proceedings is Required Pursuant
to Items 2(d) or 2(e):
- --------------------------------------------------------------------------------
6) Citizenship or Place of Organization: New Jersey
- --------------------------------------------------------------------------------
Number of 7) Sole Voting Power: 0
Shares Beneficially ----------------------------------------
8) Shared Voting Power: 0
----------------------------------------
Owned by 9) Sole Dispositive Power: 0
Each Reporting ----------------------------------------
Person With: 10) Shared Dispositive Power: 0
----------------------------------------
- --------------------------------------------------------------------------------
11) Aggregate Amount Beneficially Owned by Each Reporting Person: 0
- --------------------------------------------------------------------------------
12) Check if the Aggregate Amount in Row (11) Excludes Certain
Shares (See Instructions):
- --------------------------------------------------------------------------------
13) Percent of Class Represented by Amount in Row (11): 0%
- --------------------------------------------------------------------------------
14) Type of Reporting Person (See Instructions): CO
- --------------------------------------------------------------------------------
The Schedule 13D previously filed by Bergen Brunswig Corporation, a New
Jersey corporation ("Bergen"), with respect to the Common Stock, par value $.10
per share (the "Common Stock"), of IVAX Corporation, a Florida corporation (the
"Issuer"), is amended and supplemented as follows:
Item 2. IDENTITY AND BACKGROUND
Item 2 is amended as follows:
John Calasibetta is no longer a director or executive officer of
Bergen.
- 2 -
<PAGE>
Item 4. PURPOSE OF TRANSACTION.
Item 4 is amended and supplemented as follows:
On August 15, 1997, the Issuer and Bergen agreed to settle the then
pending litigation relating to the termination of the Agreement and Plan of
Merger (the "Merger Agreement"), dated as of November 10, 1996, between, among
others, the Issuer and Bergen. Pursuant to the terms of the settlement, each of
(i) the Stock Option Agreement, dated November 10, 1996, between the Issuer and
Bergen relating to an option to purchase up to 30,177,347 shares of Common Stock
granted to Bergen by the Issuer, (ii) the Stock Option Agreement, dated as of
November 10, 1996, between the Issuer and Bergen relating to an option to
purchase up to 9,953,076 shares of Class A Common Stock, par value $1.50 per
share (the "Bergen Common Stock"), granted to the Issuer by Bergen, (iii) the
Voting Agreement, dated as of November 10, 1996, between the Issuer and Robert
E. Martini, pursuant to which Mr. Martini agreed to vote his shares of Bergen
Common Stock in favor of the transactions contemplated by the Merger Agreement,
and (iv) the Voting Agreement, dated as of November 10, 1996, between Bergen and
Dr. Phillip Frost, pursuant to which Dr. Frost agreed to vote his shares of
Common Stock in favor of the transactions contemplated by the Merger Agreement
were terminated.
Signature
After reasonable inquiry and to the best of the undersigned's
knowledge and belief, the undersigned hereby certifies that the information set
forth in this statement is true, complete and correct.
BERGEN BRUNSWIG CORPORATION
By: /s/ Milan A. Sawdei
--------------------------------------------
November 4, 1998 Name: Milan A. Sawdei
Title: Executive Vice President,
Chief Legal Officer and Secretary
